Masaki Fukuda

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 5

Top Topics

Hematopoietic Stem Cell

Top Venues

Clinical drug investigation

This page only lists publications with an associated author ORCID identifier.

Publications

Masaki Fukuda, Junko Hattori, Rika Ohkubo, Asuka Watanabe, Shinichiroh Maekawa
Real-World Safety and Effectiveness of Letermovir in Patients Undergoing Allogenic Hematopoietic Stem Cell Transplantation: Final Results of Post-Marketing Surveillance in Japan. Clinical drug investigation 44 (7) (2024)
Masaki Fukuda, Junko Hattori, Rika Ohkubo, Asuka Watanabe, Shinichiroh Maekawa
Real-World Safety and Effectiveness of Letermovir in Patients Undergoing Allogenic Hematopoietic Stem Cell Transplantation: Final Results of Post-Marketing Surveillance in Japan. Clinical drug investigation 44 (7) (2024)
Masaki Fukuda, Junko Hattori, Rika Ohkubo, Asuka Watanabe, Shinichiroh Maekawa
Real-World Safety and Effectiveness of Letermovir in Patients Undergoing Allogenic Hematopoietic Stem Cell Transplantation: Final Results of Post-Marketing Surveillance in Japan. Clinical drug investigation (2024)
Masaki Fukuda, Junko Hattori, Rika Ohkubo, Asuka Watanabe, Shinichiroh Maekawa
Real-World Safety and Effectiveness of Letermovir in Patients Undergoing Allogenic Hematopoietic Stem Cell Transplantation: Final Results of Post-Marketing Surveillance in Japan. Clinical drug investigation 44 (7) (2024)
Masaki Fukuda, Junko Hattori, Rika Ohkubo, Asuka Watanabe, Shinichiroh Maekawa
Real-World Safety and Effectiveness of Letermovir in Patients Undergoing Allogenic Hematopoietic Stem Cell Transplantation: Final Results of Post-Marketing Surveillance in Japan. Clinical drug investigation 44 (7) (2024)